• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ethics, human rights and programmatic management of drug-resistant tuberculosis.

作者信息

Dholakia Yatin N

机构信息

The Maharashtra State Anti Tuberculosis Association, Hon. Secretary and Technical Adviser E-mail:

出版信息

Lung India. 2012 Jan;29(1):95-6. doi: 10.4103/0970-2113.92384.

DOI:10.4103/0970-2113.92384
PMID:22345934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3276055/
Abstract
摘要

相似文献

1
Ethics, human rights and programmatic management of drug-resistant tuberculosis.耐药结核病的伦理学、人权与项目管理
Lung India. 2012 Jan;29(1):95-6. doi: 10.4103/0970-2113.92384.
2
Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan.巴基斯坦旁遮普省治疗中心耐多药结核病死亡率相关因素及其规划管理
J Pak Med Assoc. 2017 Jun;67(6):858-862.
3
Programmatic and ethical challenges in the implementation of treatment-as-prevention in the context of HIV and drug-resistant tuberculosis co-infection in sub-Saharan Africa.
Glob Public Health. 2016 Mar;11(3):336-347. doi: 10.1080/17441692.2014.988164. Epub 2014 Dec 16.
4
Global scale-up of the programmatic management of multidrug-resistant tuberculosis.耐多药结核病规划管理在全球范围内的推广。
Indian J Tuberc. 2014 Apr;61(2):108-15.
5
Extensively drug resistant tuberculosis in Mali: a case report.马里广泛耐药结核病：一例报告
BMC Res Notes. 2017 Nov 6;10(1):561. doi: 10.1186/s13104-017-2890-4.
6
Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.巴布亚新几内亚西部省份结核病规划控制的情景分析
Am J Epidemiol. 2016 Jun 15;183(12):1138-48. doi: 10.1093/aje/kwv323. Epub 2016 May 19.
7
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.估算印度、菲律宾、俄罗斯和南非耐多药及广泛耐药结核病的未来负担：一项数学建模研究
Lancet Infect Dis. 2017 Jul;17(7):707-715. doi: 10.1016/S1473-3099(17)30247-5. Epub 2017 May 9.
8
Management of multidrug resistant tuberculosis.耐多药结核病的管理。
Semin Respir Crit Care Med. 2013 Feb;34(1):44-59. doi: 10.1055/s-0032-1333546. Epub 2013 Mar 4.
9
Tetany in an Extensively Drug Resistant Tuberculosis (XDR-TB) Patient Treated with Capreomycin.一名接受卷曲霉素治疗的广泛耐药结核病（XDR-TB）患者出现手足搐搦症。
J Assoc Physicians India. 2019 Aug;67(8):79-82.
10
Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis.为何《儿童权利公约》必须成为实现受结核病影响儿童权利的指导框架。
BMC Int Health Hum Rights. 2016 Dec 8;16(1):32. doi: 10.1186/s12914-016-0105-z.

引用本文的文献

1
Clinical profile and treatment outcomes of drug-resistant tuberculosis before directly observed treatment strategy plus: Lessons for the program.直接观察治疗策略加强化治疗前耐多药结核病的临床特征及治疗结果：项目经验教训
Lung India. 2013 Oct;30(4):316-20. doi: 10.4103/0970-2113.120608.

本文引用的文献

1
Status report on RNTCP.
Indian J Tuberc. 2011 Jul;58(3):132-5.
2
Tuberculosis chemotherapy in the 21 century: Back to the basics.21世纪的结核病化疗：回归基础
Lung India. 2011 Jul;28(3):193-200. doi: 10.4103/0970-2113.83977.
3
RNTCP and tuberculosis control - High time to act.印度国家结核病控制规划与结核病防治——是时候行动起来了。
Lung India. 2010 Jul;27(3):108-10. doi: 10.4103/0970-2113.68303.
4
Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.耐多药结核病的治疗结局：系统评价和荟萃分析。
PLoS One. 2009 Sep 9;4(9):e6914. doi: 10.1371/journal.pone.0006914.
5
High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.印度西部一个大城市（孟买）的修订后国家结核病控制规划中，新发病例和治疗失败患者中耐多药结核病的高流行情况。
BMC Public Health. 2009 Jun 29;9:211. doi: 10.1186/1471-2458-9-211.
6
Randomized trials to optimize treatment of multidrug-resistant tuberculosis.优化耐多药结核病治疗的随机试验。
PLoS Med. 2007 Nov 6;4(11):e292. doi: 10.1371/journal.pmed.0040292.
7
Cost-effectiveness of treating multidrug-resistant tuberculosis.治疗耐多药结核病的成本效益
PLoS Med. 2006 Jul;3(7):e241. doi: 10.1371/journal.pmed.0030241.